COMPARISON OF FAILURE RATE OF TEMPORARY ANCHORAGE DEVICES PLACED WITH PLATELET RICH PLASMA AND PLACEBO OVER SIX MONTHS: A SPLIT MOUTH RANDOMIZED CLINICAL TRIAL
DOI:
https://doi.org/10.55519/JAMC-01-12852Abstract
Background: The aim of this in vitro research was to compare and evaluate the stability of TADs coated with PRP over 6 months. TAD stability is essential for the long-term success of orthodontic treatment. PRP has become a valuable adjunct to promote healing in many procedures of oral surgery. The use of PRP in combination with bone grafts in dental treatments yields positive results in terms of improving the handling properties of the grafts and enhancing the quantity and quality of the newly formed bone. Methods: This study was conducted at Islamic International Dental College, Orthodontic Department for 6 months from April 2018 to February 2019. It was a triple-blinded study using split-mouth randomized clinical trial. Comparison of Failure of Temporary Anchorage Devices inserted with Platelet Rich Plasma and Platelet Poor Plasma (placebo) was done on 25 patients with TADs placed on the right and left sides (total of 50 TADs). Patients who had visited for comprehensive orthodontic treatment were screened according to inclusion and exclusion criteria to be included in the study. The consent form was designed in which the procedure and the reason for the study were explained to every patient selected. Each patient was given the consent form which was signed by the patient. Injection of a few drops of PRP into the pilot hole by an 18 gauge needle syringe and similarly PPP (Placebo) onto the opposing site was done. The operator was blinded during the procedure. Patients were advised to report if there was any failure of TAD.TADs were assessed on every orthodontic visit (monthly) for 6 months. Results: The total number of patients was 25, each with TAD on both the right and left sides. In a total of 50 TADs, 5 (10%) failed, 4 (8% of the total) of the left side and 1 (2% of the total) of the right side Out of these 25, 14 (56%) were males and 11 (44%) were females. In 25 patients only 1 (4%) patient showed both left and right side failure while 4 (16%) patients showed only left side failure. In terms of PPP (placebo) and PRP, the rate of failure were 3 (12%) of PPP and 2 (8%) for PRP. The mean days of failure were 46.00±3.22 and 6.50±9.192 for PPP and PRP respectively. Conclusion: From this study, it was noticed that there was no significant difference in the stability of TADs injected with PRP or PPP (placebo). Other factors such as gender, and patient or operator handedness were also not significant.References
Kravitz ND, Kusnoto B, Tsay TP, Hohlt WF. The use of temporary anchorage devices for molar intrusion. J Am Dent Assoc 2007;138(1):56–64.
Markic G, Katsaros C, Pandis N, Eliades T. Temporary anchorage device usage: a survey among Swiss orthodontists. Prog Orthod 2014;15(1):29.
Leo M, Cerroni L, Pasquantonio G, Condò S, Condò R. Temporary anchorage devices (TADs) in orthodontics: review of the factors that influence the clinical success rate of the mini-implants. Clin Ter 2016;167(3):70–7.
Takaki T, Tamura N, Yamamoto M, Takano N, Shibahara T, Yasumura T, et al. Clinical study of temporary anchorage devices for orthodontic treatment. Bull Tokyo Dent Coll 2010;51(3):151–63.
Fennis J, Stoelinga P, Jansen J. Mandibular reconstruction: a histological and histomorphometric study on the use of autogenous scaffolds, particulate cortico-cancellous bone grafts and platelet rich plasma in goats. Int J Oral Maxillofac Surg 2004;33(1):48–55.
Tripodi A. Thrombin Generation Assay and Its Application in the Clinical Laboratory. Clin Chem 2016;62(5):699–707.
Menezes LM, Rao J. Long-term clinical evaluation of platelet-rich plasma in the treatment of human periodontal intraosseous defects: A comparative clinical trial. Quintessence Int 2012;43(7):571–82.
Kumar KJ, Rao JB, Kumar BP, Mohan A, Patil K, Parimala K. A prospective study involving the use of platelet rich plasma in enhancing the uptake of bone grafts in the oral and maxillofacial region. Int J Oral Maxillofac 2013;12(4):387–94.
Bousnaki M, Bakopoulou A, Koidis P. Platelet-rich plasma for the therapeutic management of temporomandibular joint disorders: a systematic review. Int J Oral Maxillofac 2018;47(2):188–98.
Harnack L, Boedeker R, Kurtulus I, Boehm S, Gonzales J, Meyle J. Use of platelet-rich plasma in periodontal surgery—a prospective randomised double blind clinical trial. Clin Oral Investig 2009;13(2):179–87.
Marukawa E, Oshina H, Iino G, Morita K, Omura K. Reduction of bone resorption by the application of platelet-rich plasma (PRP) in bone grafting of the alveolar cleft. J Craniomaxillofac Surg 2011;39(4):278–83.
Monov G, Fuerst G, Tepper G, Watzak G, Zechner W, Watzek G. The effect of platelet‐rich plasma upon implant stability measured by resonance frequency analysis in the lower anterior mandibles: A pilot study. Clin Oral Implants Res 2005;16(4):461–5.
Garcia RV, Gabrielli MAC, Hochuli-Vieira E, Spolidorio LC, Filho JGP, Neto FAD, et al. Effect of platelet-rich plasma on peri-implant bone repair: a histologic study in dogs. Oral Implantol 2010;36(4):281–90.
Birang R, Torabi A, Shahabooei M, Rismanchian M. Effect of plasma-rich in platelet-derived growth factors on peri-implant bone healing: An experimental study in canines. J Dent Res 2012;9(1):93–9.
Nankani S, Punjabi SK, Khawaja N, Shams S. Efficacy of Platelet Rich Plasma (PRP) Gel in Bone Regeneration of Periapical Cystic Lesion. J Bio Sci 2020;2(3):379–83.
Liou EJ. The development of submucosal injection of platelet rich plasma for accelerating orthodontic tooth movement and preserving pressure side alveolar bone. APOS Trends Orthod 2016;6(1):5–11.
Tezel A, Orbak R, Çanakçi V. The effect of right or left-handedness on oral hygiene. Int J Neurosci 2001;109(1-2):1–9.
Additional Files
Published
Issue
Section
License
Copyright (c) 2024 Nofil Ahmad, Owais Khalid Durrani, Faiza Ijaz, Zuhaa Mushtaq, Iram Abbas
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.